JDD

Acne News with Dr. Adam Friedman
acne
by NEXT STEPS IN DERM TEAM on
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris …
Lessons from the Skin Microbiome: Innate Immunity, Skin Disease, and COVID-19
skin microbiome
by Azam Qureshi, MD on
While I was beginning the process of “scrubbing in” to assist in the hemicolectomy case as an intern, I carefully squeezed the anti-septic chlorhexidine-soaked sponge and watched the brown solution drip its way down my forearms. I continued the ritual by cleaning under the fingernails and on every plane of the fingers, hands, and forearms multiple times. After all; “Clean Hands Save Lives, …
JDD February 2021 Issue Highlights: Acne and Depression to “Inflammaging”
Acne
by NEXT STEPS IN DERM TEAM on
The February issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from acne and depression to "Inflammaging. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Efforts are needed to implement a clinically useful definition of moderate plaque psoriasis in Dermatologists’ Perspectives on Defining Moderate Ps …
Patient Buzz: COVID-19 & Telogen Effluvium
Telogen Effluvium
by Allison Sit on
VeryWell Health recently posted an article about a study that showed stress from COVID-19 -- and perhaps the virus itself – may be leading to an increase in hair loss cases. For an expert opinion, I contacted Chesahna Kindred, MD, MBA, FAAD, a dermatologist in practice in Columbia, Md. Has the pandemic led to an increase in telogen effluvium?  Absolutely. I noticed an increase in te …
5-Fluorouracil Therapeutic Cheat Sheet
Fluoroplex
by Blair Allais, MD on
Actinic keratoses represent the most common dermatologic diagnosis in patients older than 45 years old in the United States and account for 5.2 million visits annually.1 Cutaneous field cancerization represents areas with a high burden of both clinical and subclinical actinic damage. Cryotherapy can often be combined with topical chemotherapy for a synergistic approach. We continue our series, The …